Vanderbilt Vaccine Center

• 
• 
• 
• 

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

Along with the blast of arctic air that put much of the U.S. into a deep freeze at the start of 2018, the new year also ushered in one of the most widespread—and deadly—flu seasons in recent memory. Dr. James Crowe, director of the Vanderbilt Vaccine Center, hopes to solve this problem by eliminating the guesswork altogether.